Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HHT”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Not applicableStudy completedNCT05954481
What this trial is testing

Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaRendu Osler Disease
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT03910244
What this trial is testing

Pomalidomide for the Treatment of Bleeding in HHT

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
The Cleveland Clinic 145
Testing effectiveness (Phase 2)Looking for participantsNCT04976036
What this trial is testing

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Dr. Romain Lazor 48
Testing effectiveness (Phase 2)UnknownNCT02874326
What this trial is testing

Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaGastrointestinal HemorrhageAnemia
Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00375622
What this trial is testing

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Rabin Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT04646356
What this trial is testing

Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEpistaxis Nosebleed
Unity Health Toronto 10
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT00114959
What this trial is testing

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Who this might be right for
Myeloid Leukemia, ChronicMyeloid Leukemia, Chronic, Accelerated-PhaseBlast Phase+1 more
ChemGenex Pharmaceuticals 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091006
What this trial is testing

Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML

Who this might be right for
Relapse Leukemia
Ruijin Hospital 44
Not applicableActive Not RecruitingNCT01158807
What this trial is testing

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Unity Health Toronto 2,272
Testing effectiveness (Phase 2)Study completedNCT03397004
What this trial is testing

Doxycycline for Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
Unity Health Toronto 13
Not applicableStudy completedNCT06039124
What this trial is testing

Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH

Who this might be right for
Hemorrhagic Hereditary TelangiectasiaHHT
Hospices Civils de Lyon 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Early research (Phase 1)WithdrawnNCT07255846
What this trial is testing

A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
Terremoto Biosciences Inc.
Large-scale testing (Phase 3)Study completedNCT01031992
What this trial is testing

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
University Hospital, Saarland 23
Not applicableLooking for participantsNCT06259292
What this trial is testing

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaArteriovenous MalformationsTelangiectasia+4 more
Cure HHT 10,000
Not applicableLooking for participantsNCT07414446
What this trial is testing

Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device

Who this might be right for
Hereditary Haemorrhagic TelangiectasiaPFO - Patent Foramen OvalePulmonary Arteriovenous Malformation
St. Antonius Hospital 40
Not applicableStudy completedNCT05752253
What this trial is testing

Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Early research (Phase 1)WithdrawnNCT01406639
What this trial is testing

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Nosebleeds
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT01402531
What this trial is testing

Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
University of California, San Diego 10
Load More Results